P-32 ACCESSIBILITY TO SEQUENTIAL SYSTEMIC TREATMENT AFTER TACE: IMPACT ON SURVIVAL IN A LATIN AMERICAN PROSPECTIVE COHORT FEDERICO PIÑERO; Margarita Anders; Carla Bermúdez; Diego Arufe; Adriana Varón; Ana Palazzo; Jorge Rodríguez; Oscar Beltrán; Patricio Palavecino Rubilar; Leonardo Gomes da Fonseca; Ezequiel Ridruejo; Norberto Tamagnone; Hugo Cheinquer; Nicolás Cortés Medina; Juan Ignacio Marín; Estela Manero; Federico Orozco Ganem; Jaime Poniachik; Sebastián Marciano; Virginia Reggiardo; Manuel Mendizabal;

P-53 IMMUNE-MEDIATED ADVERSE EVENTS FOLLOWING ATEZOLIZUMAB PLUS BEVACIZUMAB IS ASSOCIATED WITH DECREASED SURVIVAL IN PATIENTS WITH CIRRHOSIS FEDERICO PIÑERO; Margarita Anders; Carla Bermúdez; Ezequiel Demirdjian; Adriana Varón; Daniela Perez; Jorge Rodriguez; Oscar Beltrán; Javier Delgado García; Leonardo Gomes da Fonseca; Ezequiel Ridruejo; Pablo Caballini; Alexandre Araujo; Juan Diego Torres Florez; Juan Ignacio Marín; Marina Villa; Federico Orozco Ganem; Jaime Poniachik; Sebastián Marciano; Fernando Bessone; Marcelo Silva; Manuel Mendizabal;

O3- RECOMPENSATION IN PATIENTS WITH CIRRHOSIS PRIOR TO FIRST LINE SYSTEMIC THERAPY IS ASSOCIATED WITH SIMILAR SURVIVAL OUTCOMES COMPARED TO COMPENSATED CIRRHOSIS FEDERICO PIÑERO; Margarita Anders; Carla Bermúdez; Diego Arufe; Adriana Varón; Ana Palazzo; Jorge Rodriguez; Oscar Beltrán; Daniela Simian; Leonardo Gomes da Fonseca; Ezequiel Ridruejo; Norberto Tamagnone; Hugo Cheinquer; Diana Bejarano; Juan Ignacio Marín; Federico Orozco Ganem; Josefina Pagés; Jaime Poniachik; Sebastián Marciano; Virginia Reggiardo; Manuel Mendizabal;